# pharma-dashboard-
This project provides a deep-dive analysis of pharmaceutical sales data across the German and Central European markets from 2017 to 2020. The dashboard tracks performance across multiple dimensions including distributors, product classes, and sales representative performance to drive strategic decision-making.

## Questions (KPIs) 

- Market Trends: How have sales fluctuated over the 4-year period (2017-2020), and where were the peak performance months?

- Channel Performance: Which sales channels (Hospital vs. Pharmacy) and sub-channels (Government, Private, Institution, Retail) contribute most to the revenue?

- Product Analysis: Which product classes (Analgesics, Antiseptics, etc.) are generating the highest revenue?

- Geographical Insights: Which cities in Germany and surrounding regions show the highest sales density?

- Rep Performance: How is the sales contribution distributed among the top sales representatives like Sheila Stones and Morris Garcia?

  - dashboard interaction <a href=  "https://github.com/mohamed231177/pharma-dashboard-/commit/30fedf61bd32e2ca0380e8e06f6ad2293265c956">view dahboard </a>

  ## process
- Data Cleaning & ETL: Handled large-scale pharmaceutical datasets, ensuring accuracy in currency and unit measurements.

- Data Modeling (Star Schema): * Structured the data using a Star Schema for optimal performance.
  
- DAX Implementation: Created complex measures to calculate "Distributor Sales %" and "Sales Channel Contribution".

- Geospatial Mapping: Integrated a map visualization to track the "Sum of Sales by City" across Germany.


## dashboard 


<img width="1366" height="733" alt="page 1" src="https://github.com/user-attachments/assets/af76ded8-4474-43f2-b907-dafb3ff66853" />
<img width="1420" height="778" alt="page 2" src="https://github.com/user-attachments/assets/707e8510-d4b0-474e-92c4-001f4d5d8227" />
<img width="1416" height="787" alt="page 3" src="https://github.com/user-attachments/assets/147f94cb-06a8-4d12-9a65-ffe5ff8a30d8" />

## Final Conclusion 
- trategic Revenue: The business achieved a massive $11.8 Billion in total sales, driven by a high volume of 29 Million units sold.

- Market Leadership: Gerlach LLC and Koss are the dominant distributors, together controlling over 55% of the total market share.

- Product Performance: Analgesics and Antiseptics are the primary revenue drivers, contributing over $4.6 Billion combined.

- Sales Force Efficiency: Revenue is evenly distributed among top sales representatives, with each maintaining a consistent contribution of approximately 20%.


